Chronic myeloproliferative disorders: the role of tyrosine kinases in pathogenesis, diagnosis and therapy.

Chronic myeloproliferative disorders: the role of tyrosine kinases in pathogenesis, diagnosis and therapy.

Item
http://www.wikidata.org/entity/Q36857947
Phenotypic variability within the JAK2 V617F-positive MPD: roles of progenitor cell and neutrophil allele burdens.Chemical and pathway proteomics: powerful tools for oncology drug discovery and personalized health care.Elevated expression of SOX2 and FGFR1 in correlation with poor prognosis in patients with small cell lung cancer.CBL mutations in myeloproliferative neoplasms are also found in the gene's proline-rich domain and in patients with the V617FJAK2.Centrosomal targeting of tyrosine kinase activity does not enhance oncogenicity in chronic myeloproliferative disorders.Quantification of PDGFRA alternative transcripts improves the screening for X-PDGFRA fusions by reverse transcriptase-polymerase chain reaction.P2Y6 Receptor Antagonist MRS2578 Inhibits Neutrophil Activation and Aggregated Neutrophil Extracellular Trap Formation Induced by Gout-Associated Monosodium Urate Crystals.
P2860

Chronic myeloproliferative disorders: the role of tyrosine kinases in pathogenesis, diagnosis and therapy.

Item
http://www.wikidata.org/entity/Q36857947
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Chronic myeloproliferative dis ...... enesis, diagnosis and therapy.
@en
type
label
Chronic myeloproliferative dis ...... enesis, diagnosis and therapy.
@en
prefLabel
Chronic myeloproliferative dis ...... enesis, diagnosis and therapy.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Chronic myeloproliferative dis ...... genesis, diagnosis and therapy
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698